Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial. Andrea Alemany , Pere Millat-Martinez , Marc Corbacho-Monné , Clara Suñer , Cristina Galvan-Casas , Caty Carrera , Dan Ouchi , Núria Prat , Jordi Ara , Nuria Nadal , Ricard Riel , Blanca Funollet , Carmen Ojeda-Ciurana , Lluis Esteve Balague , Betlem Salvador-González , Anna Forcada Arcarons , Josep Vidal-Alaball , María Isabel Del Cura-González , Ricardo Rodríguez Barrientos , Rafel Ramos-Blanes , Alberto Alum Bou , Elsa Mondou , Mireia Torres , Neus Campins , Ana Sanz , Yonggiang Tang , Miquel Àngel Rodriguez-Arias , Quique Bassat , Bonaventura Clotet , Oriol Mitjà EClinicalMedicine（2023）
关键词
Antibody therapies, Asymptomatic individuals, COVID-19, Hyperimmune immunoglobulin, Outpatients, SARS-CoV-2
AI 理解论文
溯源树
样例
